The authors and others have demonstrated that supraspinal opiate receptors and spinal ff2 adrenoceptors are involved in the analgesic mechanism for nitrous oxide (N,O). The authors hypothesize that activation of opiate receptors in the periaqueductal gray results in the activation of a descending noradrenergic pathway that releases norepinephrine onto a, adrenoceptors in the dorsal horn of the spinal cord.
as an analgesic Was described more than 150 yr ago, its mechanism of action has not been defined. Many lines of evidence indicate that N 2 0 has its analgesic action by ported that a, adrenoceptors in the spinal cord' were necessary to transduce the acute antinociceptive response to NzO. A mechanism of action for N,O also has been proposed in which opiate receptors are activated through the release of endogenous ODiate ligand~.,-~ trexOne (10 mg/k% intraPeritonedY) before %O* In a w i d activating discrete neuronal pathways. Recently, we re-
and norepinephrine was still after h Of
The periaqueductal gray (PAG) has long heen known to exposure. The increased norepinephrine release was prevented by previous administration of naltrexone. Depletion of norepibe an important site for the analgesic action of opiates (Cf 7 . We' and others8 demonstrated that the analgesic properties of N,O could be blocked by the discrete introduction of opiate antagonists directly into the PAG.
cluding the circuitry involved between the opiate recep-
In this series of studies we sought to answer the folwere externalized in the lumber region. The skin was then sutured around the tubing. 
Methods
The experimental protocol was approved by the Animal Care and Use Committee at the Palo Alto Veterans Administration Medical Center. Male Sprague-Dawley rats (Bantin and Kingman, Fremont, CA) weighing 250 -380 g were used. All tests were performed between 9 AM and 4 PM. A total of 104 rats were used. Each animal was used for only one set of studies to eliminate possible interaction between different doses and routes of drugs.
Microdialysis
The modified methods of Skilling et al.," Liu et al.,"' and Peng et al." were followed. Briefly, male SpragueDawley rats (300 -400 g) were anesthetized with isoflurane and the lateral surfaces of vertebra T13 were exposed. Bilateral holes were made through the bone to expose the spinal cord at the level of the dorsal horn.
Except for a 2-mm dialysis zone, dialysis fibers (diameter 200 mm; molecular weight cutoff = 9,000; Spectrum Laboratories, Lagund Hills, CA) were coated with a thin layer of silicon rubber. One end of the fiber was connected to a 90" angled stainless tubing made from a 22-gauge stainless steel needle. A stainless steel dissecting pin was affixed to the lumen of the other end of the fiber. By pushing the pin through the spinal cord and pulling it out the other side, the fiber was positioned so the uncoated portion of the fiber was located within the dorsal horn of the spinal cord. The pin was then cut and the free end of the fiber was attached to a length of PE 20 tubing (Clay AddmS, Sparks, MD) with cyanoacrylic glue (Krazy Gl~ie; Elmer's Products, Inc., Columbus, OH). The dialysis fiber, the initial part of the stainless tubing and PE 20 tubing were affixed to the exposed vertebra T13 with dental acrylic, and both tubing ends The next day, any animals displaying any signs of limb paralysis were rejected for further study. In the remaining, neurologically intact animals, the two tubing ends were attached to the fluid swivel in the CMA/120 system (Stockholm, Sweden) to allow for free movement, then attached to an infusion pump (Harvard Apparatus, South Natick, MA). The spinal cord was perfused with an artificial cerebrospinal fluid (aCSF) solution (NaC1: 125 mM; NaH,PO,: 0.5 mM; KCI: 2.5 mM; Na,HPO,: 2.0 mM; MgC1,: 0.25 mM; and CaCl,: 1 .O mM; pH adjusted to 7.2) at a flow rate of 1.3 pl/min for 180 min to establish a diffusion equilibrium. Samples were collected at 30-min intervals in a vial containing 0.9 pl perchloric acid to achieve a final concentration of 2% and analyzed immediately after collection. All tubing and collection vials were covered with aluminum foil to prevent degradation of norepinephrine by light.
Chromatographic Conditions. Norepinephrine was separated by reverse-phase chromatography on an ESA column (catecholamine R-80; ESA Microdialysis, Medford, MA) maintained at 24°C with a column heater. The mobile phase (Cat-A-Phase; ESA) was delivered at a flow rate of 1.0 ml/min using a Beckman 118 Solvent Module (Fullerton, CA). Samples (20 pl) were injected with a €310-RAD Model AS-100 HPLC Automatic Sampling System (Hercules, CA), and norepinephrine was detected coulometrically (model 501 1; ESA). Potentials for the first and second electrodes were set at +100 mV and -300 mV, respectively. A conditioning cell was set at + 350mV and was placed before the analytic cell. Retention time, peak area, and concentrations of norepinephrine in the dialysate were measured by comparison with known standards and were determined with the Dynamax MacIntegrator software system (Rainin Instrument Co., Inc., Emeryville, CA). The detection limit for norepinephrine in our assay varied between 0.5-1.6 pg/ sample.
Histologic Examination. To verify that the fiber traversed the dorsal horn, the spinal cord was removed and fixed in 10% formalin for histologic confirmation of cannula placement. Only animals with the cannula located below lamina I and above the central canal were included in the study.
Spinal Cord Transection
Rats were anesthetized with halothane, and laminectomy was performed at the T3-T4 level. Spinous pro-cesses and laminae were removed to expose a circular region of dura. The dura was opened and the spinal cord was severed at the T3-T4 level. The muscles were sutured over the laminectomy site and the skin was closed with wound clips. The animals were exposed to N,O and tested for tail flick response within 6 h after surgery.
Intruthecal Administration of DSP-4
Rats were anesthetized with isoflurane, an incision was made over the cervical spine, and a small puncture was made in the dura mater. PE-10 polyethylene tubing (0.28 mni ID) was threaded 8.5 cm into the intrathecal space so the tip of the catheter was positioned at the lumbar level. This tubing was then sutured in place, and the skin was sutured over the tubing. After allowing 7 days for recovery, DSP-4 (100 or 300 pg) was administered in 10 ~1 normal saline using a perfusion pump at a rate of 10 pl/rnin followed by a 10-pl flush of normal x h e . Behavioral testing or killing for the determinatioc of spinal norepinephrine levels was performed 10 days later.
The levels of norepinephrine in the lumbar enlargement of spinal cord were measured using the highperformance liquid chromatography. Rats were exposed to 100% carbon dioxide for 35 s and then killed. The spinal cord was rapidly extruded from the spinal canal using ice-cold saline; the lumbar enlargement was isolated and weighed. The tissue was put into 600 p1 perchloric acid, 2%, and 2 X 1 O p 8~ dihydroxybenzylamine, and homogenized and centrifuged at 1 , 2 0 0~ for 15 min at 4'C. The supernatant was removed and stored at -80°C for later analysis.
Nociceptive Testing Procedures
Nociception was assessed by the tail flick response to a noxious thermal stimulus, as previously described. 'I In brief, a high-intensity light beam was focused on the tail, and the time for the rat to move its tail out of the light was recorded as tail flick latency. The latency from three sites on the tail were averaged and a cut-off time of 10 s was predetermined to prevent tissue damage. Baseline measurements consisted of a set of three tail flick determinations at 2-min intervals. Baseline tail flick latencies ranged between 3 and 4 s. In some cases, percent maximal possible effect (OAMPE) was calculated as (latency -baseline)/ (cut-off time -baseline) -100
Gas Exposures
All gas exposures were performed in a clear plastic chamber (92 X 48 X 38 cm) with a sliding door on one side (for insertion of the rats). This airtight chamber was large enough to contain the infusion pump and the analgesimeter device. Fresh test gases (10 Vmin) were introduced into the chamber via an inflow port, circulated throughout the chamber by a small fan, and purged by vacuum set to aspirate at the same rate as the fresh gas inflow. Oxygen concentration in the chamber was maintained between 22-30%, while N,O concentration was maintained at 0 or 70% by adjusting the flow rates of N,O, air, and nitrogen (Liquid Carbonic, Houston, TX). Gas concentrations were measured continuously and flow rates were adjusted appropriately to maintain the desired concentrations.
Statistics
Release data were analyzed by analysis of variance for repeated measures and a posteriori by Scheffk or Bonferroni tests. Nociceptive data were analyzed by unpaired Student t test or analysis of variance for repeated measures and a posteriori by the Bonferroni multiple comparisons test when appropriate. In rats, a dialysis fiber was placed at T12 during isoflurane anesthesia. The dialysis tubing was stabilized with dental acrylic and the ends were externalized. The following day, the inflow of the dialysis tubing was connected via a swivel to a pump, which infused artificial cerebrospinal fluid at a rate of 1.3 pllmin. Microdialysate was collected during a 60-min equilibration period, with the rats breathing air, then the rats were exposed to 70°/o N,O for 90 min. The effluent was sampled at 30-mill intervals with a fraction collector. Norepinephrine was assayed by high-performance liquid chromatography with electrochemical detection. The position of the dialysis portion of the fiber was confirmed histologically at the conclusion of the experiment. Data were analyzed by analysis of variance for repeated measures and a posteriori by Scheffc?
Results
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(data not shown), had no effect on the basal release of norepinephrine alone but blocked the N,O-evoked release ( fig. 3B ).
Depletion of Norepinephrine with DSP-4 Blocked Nitrous Oxide Analgesia
In animals pretreated with DSP-4 in which the norepinephrine levels were depressed to 22% of control values ( fig. 4A ), the baseline tail flick latency was not changed ( fig. 4B ), but the analgesic action of 70% N,O as measured by percent maximal possible effect was greatly attenuated ( fig. 4C ).
Discussion
This study shows that N,O causes the release of norepinephrine in the spinal cord in the awake freely moving rat. Thisrelease decreases with continued N,O exposure and is dependent on the presence of a functional opiate receptor. In keeping with the hypothesis that N,O analgesia is mediated by the release of norepinephrine, depletion of norepinephrine stores by DSP-4 or elimination of descending noradrenergic transmission by spinal cord transection attenuates N,O analgesia. Although spinal cord transection and the insertion of the microdialysis fiber may cause a degree of nerve injury that could modlfy norepinephrine release characteristics, all effects were temporally related to the onset of N,O exposure. Although DSP-4 treatment is known to also deplete serotonin,'* the lack of analgesic effect of By measuring neurotransmitter turnover. others have found that N,O stimulates norepinephrine turnover in various brain regions.I5 N,O also has been found to increase brain dopamine turnover, " although when turnover in discrete regions of the brain was evaluated, N,O caused a decreased turnover rate of dopamine in the hippocampus and striatum but an increase in the olfactory bulb. l5 These studies indicate that N,O causes region-specific alterations in steady state levels and turnover rates of dopamine and norepinephrine within the central nervous system. In addition, N,O suppression of the activity of wide-dynamic-range neurons, in which activity has been linked to pain transmission, depends on an intact descending inhibitory pathway."
The mechanism by which N,O affects norepinephrine release is not clear, although current evidence supports a pivotal role for release of endogenous opiate peptides.
Previously, we found that an opiate antagonist adminis tered into the PAG reduced the analgesic action of N,O.' Coupled with the current finding that N,O-evoked norepinephrine release is blocked by naltrexone, these data are consistent with the hypothesis that N,O causes the release of endogenous opiate peptides in the PAG, as has been observed by others. Candidate peptides known to be present in the PAG are enkephalin, Rndorphins, or dynorphin. 18 There is some evidence that Rndoiphins may be involved because their release is stimulated by N,O both irz vivo3 and in vitro.* Antiserum against Rndorphin but not against metenkephalin also blocked the N,O-induced antinociception in rats in the hot plate test. 19 However, other studies indicate that metenkephalin may be involved in the analgesic effect of N,O because cerebrospinal fluid levels of metenkephalin Vaken from the third ventricle of awake dogs increased significantly; no changes were noted in concentrations of dynorphin A, dynorphin B, or findorphin.' N 2 0 also caused an increase in metenkephalin-like immunoreactivity in the brain stem, spinal cord, hypothalamus, and corpus striatum in rats.2" Enkephalin-and dynorphin-containing cells are present in the PAG but are also found in many other areas of the brain2'; therefore, N,O may have an action in brain regions rostra1 to the PAG. It is known that analgesia can be evoked by electrical stimulation of various sites in the brain, such as the habenular complex,'2,2' arcuate nucleus,24 and am~gdala.,~ Similar to N,O analgesia, this analgesia is sensitive to blockade by opiate [23] [24] [25] and a-adrenergic antagonists.23325 Further work is necessary to elucidate the identity of the opiate peptides and mechanism by which N,O causes their release.
Several lines of evidence indicate that spinally projecting norddrenergic neurons mediate the antinociception produced by the activation of the PAG. Intrathecal injection of a,-adrenergic antagonists can reduce the antinociception produced by either electricalL6 or chemical2' stimulation of PAG neurons. Intrathecal injection of an a, antagonist can also attenuate the antinociception produced by microinjection of morphine in the PAC;." Additionally, discrete injection of morphine into the PAG produces an increase in norepinephrine metabolites in the spinal cord, and its analgesic effects are attenuated by previous depletion of norepinephrine stores in the spinal c o d z 9 Electrophysiologic studies also showed that a2 adrenoceptors in the spinal cord contribute to the mediation of the PAG-induced inhibition of dorsal horn cell activity.' ','O There are three nuclei from which noradrenergic neuronal projections to the spinal cord originate. IJsing the tract tracing methods and combinations of lesions with histochemical methods. numerous studies have shown that noradrenergic neuronal projection to the spinal cord originates from the A5, A6 (locus coeruleus, subcoeruleus), and A7 cell groups.31,'2 In the same substrain of animals used in this study, Basbaurn's'' laboratory showed that the locus cenlleus is the major source of noradrenergic fibers to the dorsal horn region. All these nuclei receive projections from the PAG.54-37 Subsequent studies will seek to identify which noradrenergic nucleus is responsible for the analgesic action of N,O.
We have not conclusively established whether N,Oinduced norepinephrine release is mediated by activation of the descending noradrenergic pathways at a supraspinal or spinal site. In the context of our previous studies that the analgesic response to N,O is caused by activation of opiate receptors in the PAG,' and our current finding that naltrexone blocks N,O-induced norepinephrine release in the dorsal horn of the spinal cord, we believe that the weight of evidence supports a supraspinal site of activation.
There is clear evidence that the acute antinociceptive properties of N,O decrease over a relatively short time during continuous administrati~n."-*~ The results of this study show that the release of norepinephrine also diminishes over roughly the same time span, pointing to a site for tolerance proximal to norepinephrine release. Interestingly, the ability of N,O to affect dopamine turnover also diminishes progressively. "' However, the precise site of tolerance is not known. Prolonged exposure (18 h) to N,O decreases opiate receptor density in rat brain stem,*' and this would be consistent with increased release of endogenous opiate peptides causing a down-regulation of the receptor system. This raises the possibility that, depending on the mechanism involved, "cross-tolerance" may develop to either exogenous opiate or a,-agonist administration, or both, after N,O exposure. Knowledge of the mechanism for N,O tolerance may help to identify people who might be less sensitive to the analgesic action of N,O, and also allow the design of strategies to mitigate the development of tolerance to prolong the analgesic effect of N,O. 
